Tech Company Financing Transactions
AgeneBio Funding Round
On 10/20/2014, AgeneBio raised $4.1 million in financing from private investors.
Transaction Overview
Company Name
Announced On
10/20/2014
Transaction Type
Venture Equity
Amount
$4,113,127
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1340 Smith Ave. 200
Baltimore, MD 21209
USA
Baltimore, MD 21209
USA
Phone
Website
Email Address
Overview
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michela Gallagher
VP - Bus. Development
Richard Mohs
VP - Operations
Russell Barton
VP - Operations
Sarita Foster
VP - R & D
Sharon Rosenzweig-Lipson
Browse more venture capital transactions:
Prev: 10/20/2014: HomeZada venture capital transaction
Next: 10/20/2014: Buffer venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs